These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 7931483

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of children with stage IV favorable histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Green DM, Breslow NE, Evans I, Moksness J, D'Angio GJ.
    Med Pediatr Oncol; 1996 Mar; 26(3):147-52. PubMed ID: 8544795
    [Abstract] [Full Text] [Related]

  • 3. Treatment of children with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group.
    Green DM, Breslow NE, Beckwith JB, Moksness J, Finklestein JZ, D'Angio GJ.
    J Clin Oncol; 1994 Oct; 12(10):2132-7. PubMed ID: 7931484
    [Abstract] [Full Text] [Related]

  • 4. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS, Cotton CA, Perlman EJ, Breslow NE, Kalapurakal JA, Ritchey ML, Grundy PE, Malogolowkin M, Beckwith JB, Shamberger RC, Haase GM, Coppes MJ, Coccia P, Kletzel M, Weetman RM, Donaldson M, Macklis RM, Green DM.
    J Clin Oncol; 2006 May 20; 24(15):2352-8. PubMed ID: 16710034
    [Abstract] [Full Text] [Related]

  • 5. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group.
    Green DM, Breslow NE, Beckwith JB, Finklestein JZ, Grundy PE, Thomas PR, Kim T, Shochat SJ, Haase GM, Ritchey ML, Kelalis PP, D'Angio GJ.
    J Clin Oncol; 1998 Jan 20; 16(1):237-45. PubMed ID: 9440748
    [Abstract] [Full Text] [Related]

  • 6. Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study.
    Daw NC, Chi YY, Kim Y, Mullen EA, Kalapurakal JA, Tian J, Khanna G, Geller JI, Perlman EJ, Ehrlich PF, Warwick AB, Grundy PE, Fernandez CV, Dome JS, AREN0321 Study Committee.
    Eur J Cancer; 2019 Sep 20; 118():58-66. PubMed ID: 31325873
    [Abstract] [Full Text] [Related]

  • 7. Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group.
    Green DM, Breslow NE, Beckwith JB, Finklestein JZ, Grundy P, Thomas PR, Kim T, Shochat S, Haase G, Ritchey M, Kelalis P, D'Angio GJ.
    J Clin Oncol; 1998 Dec 20; 16(12):3744-51. PubMed ID: 9850017
    [Abstract] [Full Text] [Related]

  • 8. Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study.
    Pritchard J, Imeson J, Barnes J, Cotterill S, Gough D, Marsden HB, Morris-Jones P, Pearson D.
    J Clin Oncol; 1995 Jan 20; 13(1):124-33. PubMed ID: 7799012
    [Abstract] [Full Text] [Related]

  • 9. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.
    Tournade MF, Com-Nougué C, de Kraker J, Ludwig R, Rey A, Burgers JM, Sandstedt B, Godzinski J, Carli M, Potter R, Zucker JM, International Society of Pediatric Oncology Nephroblastoma Trial and Study Committee.
    J Clin Oncol; 2001 Jan 15; 19(2):488-500. PubMed ID: 11208843
    [Abstract] [Full Text] [Related]

  • 10. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.
    Malogolowkin M, Cotton CA, Green DM, Breslow NE, Perlman E, Miser J, Ritchey ML, Thomas PR, Grundy PE, D'Angio GJ, Beckwith JB, Shamberger RC, Haase GM, Donaldson M, Weetman R, Coppes MJ, Shearer P, Coccia P, Kletzel M, Macklis R, Tomlinson G, Huff V, Newbury R, Weeks D, National Wilms Tumor Study Group.
    Pediatr Blood Cancer; 2008 Feb 15; 50(2):236-41. PubMed ID: 17539021
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of Wilms' tumour. Current recommendations.
    Mehta MP, Bastin KT, Wiersma SR.
    Drugs; 1991 Nov 15; 42(5):766-80. PubMed ID: 1723373
    [Abstract] [Full Text] [Related]

  • 13. Improved survival for children with anaplastic Wilms' tumors.
    Corey SJ, Andersen JW, Vawter GF, Lack EE, Sallan SE.
    Cancer; 1991 Sep 01; 68(5):970-4. PubMed ID: 1655221
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Better survival after combined modality care for adults with Wilms' tumor. A report from the National Wilms' Tumor Study.
    Arrigo S, Beckwith JB, Sharples K, D'Angio G, Haase G.
    Cancer; 1990 Sep 01; 66(5):827-30. PubMed ID: 2167146
    [Abstract] [Full Text] [Related]

  • 19. [Wilms' tumour of unfavorable histology--results of treatment with the SIOP 93-01 protocol at the Gdańsk centre. Preliminary report].
    Stefanowicz J, Sierota D, Balcerska A, Stoba C.
    Med Wieku Rozwoj; 2004 Sep 01; 8(2 Pt 1):197-200. PubMed ID: 15738594
    [Abstract] [Full Text] [Related]

  • 20. Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial.
    de Kraker J, Graf N, van Tinteren H, Pein F, Sandstedt B, Godzinski J, Tournade MF, SIOP.
    Lancet; 2004 Sep 01; 364(9441):1229-35. PubMed ID: 15464183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.